| Literature DB >> 26960036 |
Jacqueline Flank1,2, Paula D Robinson3, Mark Holdsworth4, Robert Phillips5,6, Carol Portwine7, Paul Gibson8, Cathy Maan8, Nancy Stefin7, Lillian Sung9,10, L Lee Dupuis1,2,10.
Abstract
This clinical practice guideline provides an approach to the treatment of breakthrough chemotherapy-induced nausea and vomiting (CINV) and the prevention of refractory CINV in children. It was developed by an international, interprofessional panel and is based on systematic literature reviews. Evidence-based interventions for the treatment of breakthrough and prophylaxis of refractory CINV are recommended. Gaps in the evidence used to support the recommendations made in this clinical practice guideline were identified. The contribution of these recommendations to breakthrough and refractory CINV control in children requires prospective evaluation.Entities:
Keywords: chemotherapy-induced nausea; chemotherapy-induced vomiting; clinical practice guideline; supportive care
Mesh:
Year: 2016 PMID: 26960036 DOI: 10.1002/pbc.25955
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167